Research programme: prostaglandin receptor agonists - Allergan
Latest Information Update: 06 Apr 2011
At a glance
- Originator Asterand plc
- Developer Allergan
- Class Small molecules
- Mechanism of Action Prostaglandin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 06 Apr 2011 No development reported - Preclinical for Eye disorders in USA (unspecified route)
- 09 Sep 2008 Preclinical trials in Eye disorders in USA (unspecified route)